Does DIPHENYLGUANIDINE Cause Product dose omission issue? 13 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product dose omission issue have been filed in association with DIPHENYLGUANIDINE. This represents 92.9% of all adverse event reports for DIPHENYLGUANIDINE.
13
Reports of Product dose omission issue with DIPHENYLGUANIDINE
92.9%
of all DIPHENYLGUANIDINE reports
6
Deaths
11
Hospitalizations
How Dangerous Is Product dose omission issue From DIPHENYLGUANIDINE?
Of the 13 reports, 6 (46.2%) resulted in death, 11 (84.6%) required hospitalization, and 4 (30.8%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIPHENYLGUANIDINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does DIPHENYLGUANIDINE Cause?
Arthropathy (14)
Lower respiratory tract infection (14)
Pulmonary pain (14)
Abdominal discomfort (12)
Knee arthroplasty (12)
Rash (12)
Drug abuse (11)
Intentional product misuse (11)
Off label use (11)
Overdose (10)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)